Go to ...

Nordens Ekonomi Norge

RSS Feed

18. november 2018

Novelion Therapeutics Reports Third Quarter 2018 Financial Results


Euroinvestor.com A/S Euroinvestor.com A/S


VANCOUVER, British Columbia, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN), a biopharmaceutical company dedicated to developing and commercializing therapies for individuals living with rare diseases (“Novelion” or the “Company”), today reported..

More Stories From

Do NOT follow this link or you will be banned from the site!
Read previous post:
Snapfish, LLC Successfully Completes Cash Tender Offer for Shares of CafePress Inc.

SAN FRANCISCO, Calif. and LOUISVILLE, Ky., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Snapfish, LLC (“Snapfish”), premier personalized photo service, today...

Close